MDT

98.12

+1.73%↑

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

MDT

98.12

+1.73%↑

146.22

-0.4%↓

VEEV

218.31

-4.16%↓

HQY

85.42

+3.09%↑

PHR.US

16.15

-2.24%↓

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Abierto

3.43 3.63

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.24

Máximo

3.54

Métricas clave
By Trading Economics
Ingresos	-3.3M -13M
Ventas	-1.4M 17M
Margen de beneficios	-77.289
Empleados	260
EBITDA	-3.2M -11M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+24.27% upside

Dividendos
By Dow Jones
Próximas Ganancias	12 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-15M 106M
Apertura anterior	-0.2
Cierre anterior	3.43

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 ene 2026, 19:05 UTC

Principales Movimientos del Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 ene 2026, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 ene 2026, 23:41 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 ene 2026, 23:33 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 ene 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 ene 2026, 23:10 UTC

Adquisiciones, fusiones, absorciones

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 ene 2026, 23:03 UTC

Charlas de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 ene 2026, 21:50 UTC

Adquisiciones, fusiones, absorciones

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 ene 2026, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 ene 2026, 21:20 UTC

Adquisiciones, fusiones, absorciones

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 ene 2026, 21:15 UTC

Adquisiciones, fusiones, absorciones

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 ene 2026, 21:08 UTC

Adquisiciones, fusiones, absorciones

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 ene 2026, 20:39 UTC

Charlas de Mercado

Silver Settles at Another New High -- Market Talk

13 ene 2026, 20:21 UTC

Charlas de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 ene 2026, 20:17 UTC

Charlas de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 ene 2026, 19:08 UTC

Adquisiciones, fusiones, absorciones

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 ene 2026, 19:03 UTC

Ganancias

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 ene 2026, 18:50 UTC

Ganancias

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 ene 2026, 17:54 UTC

Charlas de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

13 ene 2026, 17:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 ene 2026, 17:49 UTC

Charlas de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 ene 2026, 17:38 UTC

Charlas de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

13 ene 2026, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

13 ene 2026, 17:19 UTC

Charlas de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 ene 2026, 17:15 UTC

Charlas de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

24.27% repunte

Estimación a 12 Meses

Media 4.25 USD 24.27%

Máximo 5.5 USD

Mínimo 3 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.